Navigation Links
Loic Maurel Joins Exonhit Therapeutics to Become CEO
Date:6/4/2008

PARIS, June 4 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic company, today announces that Loic Maurel, M.D., will join ExonHit Therapeutics on July 1st as Chief Operating Officer. At the next meeting of the Supervisory Board, he will be appointed CEO (President du Directoire).

Laurent Condomine, Chairman of the Supervisory Board, commented: "We are delighted to have Loic Maurel joining ExonHit Therapeutics. His experience and track record in major as well as in biopharmaceutical companies, both in Europe and in North America, combined with his leadership qualities, will be of great value going into the future. Together with the newly formed Management Board, the ExonHit leadership team will focus on accelerating the Company's transformation from an R&D driven organization into a market and commercially driven company enabling ExonHit to meet its ultimate goal of providing therapeutic and diagnostic solutions in chronic diseases, in an effective and timely fashion."

Prior to joining ExonHit and since 2001, Loic Maurel served as President and CEO of Debiovision Inc. in Canada, a Pharmaceutical Development Company focusing on the development of innovative therapeutics for unmet medical needs. During his tenure, he acquired clinical and regulatory experience with FDA and EMEA exposures, filing an NDA in the United States, Canada, France, and Switzerland. He also led several licensing and acquisition activities in North America, Europe, and Asia. From 1999 to 2001, Loic Maurel was Vice President Marketing and Specialty Business of Novartis Canada. He successfully launched several products and increased sales as a result of the restructuring of the Marketing and Sales organization. Prior to this, he was Global Marketing Head for the Cardiovascular, Metabolism and Respiratory Therapeutic Area at Novartis Headquarters in Basel, Switzerland. He was responsible for the worldwide launch of Diovan, the number one product of Novartis.
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. David M. Stout Joins NanoBio Corporations Board of Directors
2. Dan Renick, RPh, Joins The Hobart Group as Managing Partner
3. Steve Davis Joins Infectious Disease Research Institute (IDRI) as Interim CEO
4. Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
5. Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate $1 To Accelerate Cancer Research
6. Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries
7. Basil Zimmo Joins Finesse Solutions as Vice-President of Software
8. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
9. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
10. Harvey Morgan Joins CryoLife Board of Directors
11. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , , CALGARY and BLENHEIM, Ontario, Nov. ...da announced today it is acquiring the assets of H...enheim, Ontario. The addition of Hyland Seeds will...siness as the company anticipates the introduction...es Herbicide Tolerant Trait Technology in corn in ...
(Date:11/24/2009)... , Health care employmen...emains the only one to show consistent growth duri...lty hospitals remain in trouble, and health system...cal personnel, instead of just administrators. , ...-- Health care employment continued growing in Oct...
(Date:11/24/2009)... , , SAN MATEO, Calif., Nov. 24 /PRNe...X ), a biopharmaceutical company focused on develo...rapies, announced today that Anthony DiTonno, Pres... present at the 21st Annual Piper Jaffray Health C...he New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)... , The FBI recently appro...laboratories participating in or generating DNA re... Madison, WI USA (PRWEB) -- The F...6 HS System for use by laboratories participating...NA Index System (NDIS). NDIS currently contains mo...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
..., A common hospital superbug called Clostridium h...ble when put into a test tube on its own, which ma..., according to scientists speaking today (Thursday...obiology,s 161st Meeting at the University of Edin...Like many other micro-organisms, Clostridium diffi...
...Special Stockholders Meeting to Approve Merger Wit... 2007, IRVINE, California, September 5 Is...ologics company, today announced the,filing of a d... and,Exchange Commission ("SEC") in connection wit...tion (NASDAQ: IART ) ("Integra") combination.,The...
...U.S. Biogeneric Agents to Reach $2 Billion in Sale...port from Decision Resources, WALTHAM, Mass., Sep... leading research and advisory firms for pharmaceu... leading manufacturer of biologic,agents with biol...enentech,the second leading biologics manufacturer...
Other Biology Technology:IsoTis Files Definitive Proxy Statement 2IsoTis Files Definitive Proxy Statement 3IsoTis Files Definitive Proxy Statement 4Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers 2
(Date:11/25/2009)... Over the course of a lifetime, the heart pumps so...n the order to do this, the muscle fibers of the h...oup headed by Dr. Wolfgang Rottbauer, vice chair o...versity Hospital (Chairman: Prof. Dr. H. A. Katus)... the stability of the smallest muscular unit, the ...
(Date:11/24/2009)... The Lupus Research Institute (LRI) today named 12...ng $3.6 million, recognize innovative work across ...ted for their creativity, novelty, and potential t..., treat, and cure the complex disease of systemic ...blished lupus researchers across the nation and in...
(Date:11/24/2009)... The atomic-level action of a remarkable class of ...esearchers with the Lawrence Berkeley National Lab...otein crystallography beamline at the Advanced Lig... roles in gene expression and replication, and are... well as infectious agents, such as the human papi...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U S HIV Clinical Studies 52096 1New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U S HIV Clinical Studies 52096 2New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U S HIV Clinical Studies 52096 3New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U S HIV Clinical Studies 52096 4New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U S HIV Clinical Studies 52096 5New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U S HIV Clinical Studies 52096 6New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U S HIV Clinical Studies 52096 7New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U S HIV Clinical Studies 52096 8New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 1New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 2New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 3New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 4New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 5New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 6Perception May Affect Drinking by College Students 52095 1Perception May Affect Drinking by College Students 52095 2
...and extraordinary $22 million gift to the Universi...new and extraordinary institute one with a missio...e understanding of the causes, treatment and preve.... Alfred Taubman Medical Research Institute, being...or the retail pioneer whose funding and vision led...
...7 -- Consuming large amounts of caffeine while tak...nkillers in the United States, could potentially c...ratory study reported in the Oct. 15 print issue o...ournal. The toxic interaction could occur not only...the painkiller but also from using large amounts o...
...fill the molecular requirements for sensing the ma...nd in retinal neurons of migratory birds (Mouritse...igating what parts of a migratory birds brain are ...howed that the cryptochrome-containing neurons in ...en et al., PNAS, 2005; Liedvogel et al., EJN, 2007...
Other Biology News:$22 million gift from Alfred Taubman launches new biomedical research institute 2$22 million gift from Alfred Taubman launches new biomedical research institute 3$22 million gift from Alfred Taubman launches new biomedical research institute 4Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage 2
Chicken Anti-Human Adenylate kinase isoenzyme 6 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Fetuin from Equitech-Bio
Goat Anti-Human Rabenosyn 5 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ZFP91 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: